Beta-lactam antibiotics in combination with novel β-lactamase inhibitors – an alternative therapy for infections caused by multidrug-resistant bacteria

.blurhash-client-img { display: none !important; }

Open Access

|Apr 2024

Authors

Medical University of Lodz, Department of Microbiology and Laboratory Medical Immunology, Łodź, Poland

Central Teaching Hospital of the Medical University of Łodź, Medical Microbiology Laboratory, Łodź, Poland

Medical University of Lodz, Department of Microbiology and Laboratory Medical Immunology, Łodź, Poland

Central Teaching Hospital of the Medical University of Łodź, Medical Microbiology Laboratory, Łodź, Poland

Medical University of Lodz, Department of Microbiology and Laboratory Medical Immunology, Łodź, Poland

Medical University of Lodz, Department of Microbiology and Laboratory Medical Immunology, Łodź, Poland

DOI: https://doi.org/10.21164/pomjlifesci.973 | Journal eISSN: 2719-6313 | Journal ISSN: 2450-4637

Language: English

Page range: 7 - 14

Published on: Apr 25, 2024

Published by: Pomeranian Medical University

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2024 Małgorzata Brauncajs, Filip Bielec, Anna Macieja, Dorota Pastuszak-Lewandoska, published by Pomeranian Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.